Screener
HealthEquity HQY Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands) | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Repurchases of common stock | (123,314) | (59,065) |
| Principal payments on long-term debt | (15,000) | — |
| Settlement of client-held funds obligation, net | 716 | 1,451 |
| Proceeds from exercise of common stock options | 418 | 965 |
| Net cash used in financing activities | (137,180) | (56,649) |
| Decrease in cash and cash equivalents | (53,558) | (8,054) |
| Beginning cash and cash equivalents | 318,927 | 295,948 |
| Ending cash and cash equivalents | $265,369 | $287,894 |
Item 1. Financial statements
FAQ
- What is HealthEquity's stock issuance proceeds?
- HealthEquity (HQY) reported stock issuance proceeds of $418K in Q1 2026.
- How has HealthEquity's stock issuance proceeds changed year-over-year?
- HealthEquity's stock issuance proceeds decreased by 56.7% year-over-year, from $965K to $418K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about HealthEquity's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude